Tudor Investment Corp’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.9M Sell
650,000
-47,457
-7% -$795K 0.02% 308
2025
Q1
$10.7M Buy
697,457
+247,456
+55% +$3.8M 0.04% 248
2024
Q4
$9.92M Sell
450,001
-365,000
-45% -$8.04M 0.04% 223
2024
Q3
$14.7M Sell
815,001
-40,000
-5% -$721K 0.05% 154
2024
Q2
$13.9M Sell
855,001
-90,048
-10% -$1.46M 0.07% 179
2024
Q1
$13.3M Sell
945,049
-11,288
-1% -$159K 0.08% 167
2023
Q4
$9.98M Buy
956,337
+61,836
+7% +$646K 0.08% 208
2023
Q3
$9.12M Buy
894,501
+208,776
+30% +$2.13M 0.09% 194
2023
Q2
$5.16M Sell
685,725
-472,253
-41% -$3.56M 0.06% 327
2023
Q1
$10.2M Buy
1,157,978
+11,859
+1% +$105K 0.16% 127
2022
Q4
$10.5M Buy
1,146,119
+21,032
+2% +$192K 0.21% 68
2022
Q3
$9.08M Buy
1,125,087
+10,000
+0.9% +$80.7K 0.2% 91
2022
Q2
$8.39M Buy
1,115,087
+415,000
+59% +$3.12M 0.22% 62
2022
Q1
$6.57M Buy
+700,087
New +$6.57M 0.15% 134
2020
Q4
Sell
-10,174
Closed -$92K 1598
2020
Q3
$92K Buy
+10,174
New +$92K ﹤0.01% 1176
2020
Q2
Sell
-10,100
Closed -$91K 1405
2020
Q1
$91K Sell
10,100
-496
-5% -$4.47K 0.01% 930
2019
Q4
$104K Buy
+10,596
New +$104K ﹤0.01% 1042
2016
Q4
Sell
-5,930
Closed -$273K 1585
2016
Q3
$273K Buy
+5,930
New +$273K 0.01% 1072
2016
Q2
Sell
-10,782
Closed -$577K 1676
2016
Q1
$577K Sell
10,782
-389,218
-97% -$20.8M 0.01% 669
2015
Q4
$26.3M Buy
400,000
+389,700
+3,783% +$25.6M 0.74% 20
2015
Q3
$582K Sell
10,300
-389,700
-97% -$22M 0.02% 635
2015
Q2
$23.6M Sell
400,000
-150,000
-27% -$8.87M 0.69% 24
2015
Q1
$34.3M Buy
+550,000
New +$34.3M 1.1% 7
2014
Q2
Sell
-300,000
Closed -$15.9M 1302
2014
Q1
$15.9M Buy
+300,000
New +$15.9M 0.67% 26